Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Abciximab (Archived)

Kevin Stoffer  1 , Karlyle G. Bistas  2 , Vamsi Reddy  3 , Saumya Shah  4
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan.
.
Affiliations
Free Books & Documents
Book

Abciximab (Archived)

Kevin Stoffer et al.
Free Books & Documents

Excerpt

Abciximab has been discontinued in the U.S.A. Researchers have studied abciximab in three phase III clinical trials: EPIC, EPILOG, and CAPTURE.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Kevin Stoffer declares no relevant financial relationships with ineligible companies.

Disclosure: Karlyle Bistas declares no relevant financial relationships with ineligible companies.

Disclosure: Vamsi Reddy declares no relevant financial relationships with ineligible companies.

Disclosure: Saumya Shah declares no relevant financial relationships with ineligible companies.

References

    1. Bedjaoui A, Allal K, Lounes MS, Belhadi CE, Mekarnia A, Sediki S, Kara M, Azaza A, Monsuez JJ, Benkhedda S. Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention. 2019 Jan/Feb 23Cardiovasc J Afr. 30(1):45-51. - PMC - PubMed
    1. Morales-Ponce FJ, Lozano-Cid FJ, Martinez-Romero P, Gonzalez-Perez P, Sanchez-Brotons JA, Diaz-Torres I, Rodriguez-Yanez JC, Caro-Mateo P, Serrador-Frutos AM. Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary percutaneous coronary intervention in patients with anterior myocardial infarction. EuroIntervention. 2019 Mar 20;14(16):1668-1675. - PubMed
    1. Ortiz-Otero N, Mohamed Z, King MR. Platelet-Based Drug Delivery for Cancer Applications. Adv Exp Med Biol. 2018;1092:235-251. - PubMed
    1. Delgado F, Oteros R, Jimenez-Gomez E, Bravo Rey I, Bautista MD, Valverde Moyano R. Half bolus dose of intravenous abciximab is safe and effective in the setting of acute stroke endovascular treatment. J Neurointerv Surg. 2019 Feb;11(2):147-152. - PubMed
    1. Drugs and Lactation Database (LactMed®) [Internet] National Institute of Child Health and Human Development; Bethesda (MD): 2023. Nov 15, Abciximab.

Publication types

LinkOut - more resources